Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.  Ann Intern Med. 2014;161(2):104-12. doi: 10.7326/M13-2867.  PubMed

Lapham GT, Rubinsky AD, Heagerty PJ, Achtmeyer C, Williams EC, Hawkins EJ, Maynard C, Kivlahan DR, Au D, Bradley KA. Probability and predictors of patients converting from negative to positive screens for alcohol misuse. Alcohol Clin Exp Res. 2014 Feb;38(2):564-71. doi: 10.1111/acer.12260. Epub 2013 Oct 7. PubMed

Lapham GT, Rubinsky AD, Williams EC, Hawkins EJ, Grossbard J, Chavez LJ, Kivlahan DR, Bradley KA. Decreasing sensitivity of clinical alcohol screening with the AUDIT-C after repeated negative screens in VA clinics. Drug Alcohol Depend. 2014 Sep 1;142:209-15. doi: 10.1016/j.drugalcdep.2014.06.017. Epub 2014 Jun 23. PubMed

Leary PJ, Jenny NS, Barr RG, Bluemke DA, Harhay MO, Heckbert SR, Kronmal RA, Lima JA, Mikacenic C, Tracy RP, Kawut SM. Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis right ventricle study. Pulm Circ. 2014;4(2):250-9. doi: 10.1086/675988.  PubMed

Lee CI, Elmore JG. Increasing value by increasing volume: call for changes in U.S. breast cancer screening practices. J Natl Cancer Inst. 2014 Mar 1;106(3):dju028. doi: 10.1093/jnci/dju028. Epub 2014 Mar 5. PubMed